AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in ...

Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical recommendations for patients.

Tempus will use its "Lens" data analytics platform to analyze and restructure genomic data from the the Abrams Research Center.

The American Medical Association has established a new policy that aims to increase transparency and trust in AI tools used in clinical care. The policy was approved during the AMA’s annual meeting ...

When two of medicine’s most outspoken reformers publish a roadmap for the FDA, you expect at least coherence. Instead, we get ...

Artificial intelligence and telemedicine are transforming dialysis care, improving predictions, expanding access, and enabling patient-centered home therapies.

Cardioneurology, the intersection of cardiac and neurological sciences, has become increasingly important due to the complex ...

There’s no shortage of big promises about AI in healthcare. The U.S. government announced a $500 billion Stargate initiative ...

The integration of Artificial Intelligence (AI) in various sectors has been nothing short of transformative, and now, it’s poised to ...

The new funding will help propel Wandercraft into its next phase of growth, which involves deploying its new humanoid robot.

Penny stocks captivate investors with their low prices. The allure of controlling large numbers of shares for relatively very ...